Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)

Abroad (travel likely)RecruitingPHASE3

Conditions

Ovarian Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital Universitario y Politécnico La Fe, Valencia, Valencia, Spain
Contact: Study coordinator (Mónica Cebrián Coordinator Clinical Research Area) · investigacion_clinica@iislafe.es · +34961246731
Contact: Principal Investigator (Víctor Lago Leal, physician)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

Ovarian Neoplasms

Abroad (travel likely)RecruitingPHASE3

Randwick, Australia · Montreal, Canada

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Gilbert, United States · Phoenix, United States

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

Ovarian Neoplasms Malignant · Ascites

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China